Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 3/20 | 0.33 |
| ▸ | HTR2A | P28223 | 2/20 | 0.33 |
| ▸ | HTR2B | P41595 | 2/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | HTR7 | P34969 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19680274 | 0.74 | DPP4 (0.34) | HTR2CHTR2ADPP4MEN1ALDH1A1 | |
| SCHEMBL12083455 | 0.72 | ALDH1A1 (0.36) | DPP4MEN1ALDH1A1POLBKMT2A | |
| SCHEMBL9891022 | 0.72 | ALDH1A1 (0.36) | DPP4MEN1ALDH1A1POLBKMT2A | |
| SCHEMBL13875989 | 0.66 | ALDH1A1 (0.37) | MEN1ALDH1A1POLBKMT2AHTR7 | |
| SCHEMBL11921033 | 0.65 | MEN1 (0.35) | MEN1ALDH1A1POLBKMT2A | |
| SCHEMBL19752363 | 0.64 | GAA (0.33) | HTR2CHTR2AMEN1ALDH1A1POLB | |
| SCHEMBL10391741 | 0.62 | HTR2C (0.42) | HTR2CHTR2AHTR2BMEN1ALDH1A1 | |
| SCHEMBL19885349 | 0.60 | KMT2A (0.52) | DPP4MEN1ALDH1A1POLBKMT2A | |
| SCHEMBL8054946 | 0.58 | BCHE (0.45) | MEN1ALDH1A1KMT2AACHE | |
| SCHEMBL16789235 | 0.58 | SLC18A3 (0.36) | HTR2CHTR2AHTR2BMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170098789-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2017-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170098789-A1 | Organic Electroluminescent Materials and Devices | OCIAD2, OCIAD1, OSBP | HTR2C 1624/4885HTR2A 2701/4885HTR2B 2415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.